Go Back

Imagine revenue management without the friction

FinThrive creates integrated technology that adapts with healthcare professionals – freeing them from complexity and inefficiency so they can focus on doing their best work. Our end-to-end revenue management platform provides financial teams and stakeholders with greater reliability and control to deliver better outcomes for everyone. With our vision, technology, experience and scale, we’re advancing the healthcare economy.

FinThrive

Healthcare

The Dynamic Duo Helping MSK Populations!

Brian Urban
July 1, 2024
Brian Urban
Dr. Alexander Ding
FinThrive
Healthcare Rethink podcast
+more

 

Discover how a dynamic duo partnered with innovative, value-based strategies to revolutionize care for MSK populations.

As musculoskeletal (MSK) conditions like osteoarthritis and back pain continue to rise, innovative partnerships are vital to delivering effective, value-based care. Recent studies show that MSK conditions are among the leading contributors to disability in the U.S., highlighting the need for comprehensive and integrated care solutions.

How can healthcare systems better manage and support MSK populations?

Welcome to Healthcare Rethink, a FinThrive podcast hosted by Brian Urban. In this episode, Urban discovers a transformative partnership between John Petito, the Chief Strategy Officer at TailorCare, and Dr. Alexander Ding, MD, MBA, a Practicing Physician Executive at Humana. They discuss their collaborative efforts in improving care for MSK populations.

Main Discussion Points:

  • The innovative approaches TailorCare and Humana are using to deliver personalized, value-based MSK care.
  • The importance of integrating clinical expertise and advanced analytics to enhance patient outcomes.
  • Future directions for expanding value-based care models to broader patient populations.

John Petito has extensive experience in healthcare strategy, focusing on building value-based care organizations from the ground up. Dr. Alexander Ding is a practicing diagnostic and interventional radiologist dedicated to advancing value-based care and improving healthcare delivery.

Recent Episodes

vitro
View episode

Analyzing the Suppressive TME in In Vitro Based Assays

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

cancer
View episode

Targeting T Cells Within the Cancer Immunity Cycle

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

cancer Immunity cycle
View episode

Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Launch Your Branded Show Today

Engage your audience with original, industry-specific content.

Book a Demo Talk to an Expert